http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Optimizing the Local Embedding of Renewable Energy Plants
Michael Krug,Dörte Ohlhorst 한국환경정책학회 2019 環境政策 Vol.27 No.S
In this article we ask about the factors that promote acceptance of local renewable energy plants and about the specific role nature conservation plays in the concert of other acceptance factors. We explored to what extent trade-offs between climate protection, nature and species protection, protection of local residents and local value creation can be realigned. The article provides an overview of the key acceptance factors identified and derives a set of trust and acceptance building measures. It has a specific focus on wind energy. Our findings suggest that nature conservation rationales have definitively a role to play as a local acceptance factor, but other acceptance factors are closely linked or more important. Particularly, economic factors, the attitudes towards the energy transition, trust in key actors and planning and development processes were identified as key preconditions for local acceptance.
Sevcan Karakoç Demirkaya,Hatice Aksu,Börte Gürbüz Özgür 대한정신약물학회 2017 CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE Vol.15 No.4
Objective: Risperidone has been widely used to control aggression and conduct disorder (CD) in youth; however, treatment compliance is a major problem in CD. Our aim is to evaluate the effectiveness and tolerability of long-acting risperidone (LAR) in treating nonadherent cases. Methods: The medical records of children and adolescents who had CD and were nonadherent to conventional drugs and psychosocial interventions (and therefore taking LAR) were reviewed. Informed consent on offlabel use of LAR was obtained from the parents. Clinical Global Impression (CGI) Severity (CGI-S) and CGI-Improvement scales were used and baseline and end points were compared. Results: The study comprised 14 children and adolescents (5 girls, 9 boys). All had comorbid disorders: substance use disorder (n=8), attention deficit hyperactivity disorder (n=6), and major depression (n=2). Mean duration of LAR use was 3.1 months (1.5-8 months). We observed significant improvements in the baseline and endpoint CGI-S scores for CD in all but one patient (Z=−3.198; p <0.001). Only mild adverse effects were observed: weight gain (n=2), sedation (n=1), leg cramps (n=1), and increased appetite with no weight gain (n=1). Conclusion: LAR is effective and tolerable for patients with CD who can’t be medicated with oral preparations due to nonadherence to treatment. Even short-term LAR use is effective to get compliance. As CD predicts numerous problems in adulthood, appropriate treatment is crucial. To our knowledge, this is the first study on LAR use in youth with CD. The use of LAR deserves careful consideration and further controlled studies are needed to confirm our findings.